Comment
0
Tweet
2
Print
RSS Feeds

Emergent BioSolutions plans to open new facility

Monday - 9/16/2013, 2:49pm  ET

In an undated photo Emergent BioSolutions Vice President Dino Muzzin holds a product sample of BioThrax, the only FDA-licensed vaccine available for pre-exposure protection against anthrax infection. The Detroit Free Press reports Monday, Sept. 16, 2013, that Emergent BioSolutions Inc. is planning to open a new Michigan facility to expand production of its BioThrax anthrax vaccine. (AP Photo/Detroit Free Press, Ryan Garza) DETROIT NEWS OUT; NO SALES

LANSING, Mich. (AP) -- Emergent BioSolutions Inc. is planning to open a new Michigan facility to expand production of its BioThrax anthrax vaccine.

The Detroit Free Press reports (http://on.freep.com/18noDXI ) Monday that the Rockville, Md.-based company says it could take until 2014 or 2015 until the Lansing facility completes a review by the U.S. Food and Drug Administration and receives certification.

CEO and President Daniel Abdun-Nabi says large-scale production has been a challenge and the expansion will help meet that goal.

Emergent BioSolutions announced in 2011 that the U.S. government formally ordered 44.8 million doses of BioThrax anthrax vaccine in an agreement worth as much as $1.25 billion over five years.

___

Information from: Detroit Free Press, http://www.freep.com


Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.